mDR Limited Announces Significant Acquisition of Quoted Securities
mDR Limited Announces Significant Acquisition of Quoted Securities
Key Details from Latest SGX Announcement
mDR Limited (“the Company”), together with its subsidiaries (“the Group”), has announced a substantial acquisition and sale of quoted securities, as disclosed under Rule 704(17)(b) and Rule 704(18)(b) of the Singapore Exchange Securities Trading Limited (SGX-ST) Listing Manual.
Highlights of the Announcement
-
Acquisition of Quoted Securities: The Group acquired quoted securities amounting to approximately S\$6,230,888 during the period from 18 December 2025 to 29 December 2025.
-
This acquisition represents 4.2% of the Group’s latest audited consolidated net tangible assets (NTA).
-
Sale of Quoted Securities: The Group sold quoted securities valued at approximately S\$150,010 (based on historical cost) over the same period. This sale represents 0.1% of the latest audited consolidated NTA.
-
As of 31 December 2024, the Group’s audited consolidated net tangible assets stand at S\$148,431,000.
Impact on the Group’s Investment Portfolio
|
Before Acquisition |
After Acquisition |
| Aggregate cost of quoted investments (S\$’000) |
298,790 |
307,516 |
| Aggregate cost as % of latest audited consolidated NTA |
201.3% |
207.2% |
| Total market value of quoted investments (S\$’000) |
217,434 |
220,281 |
| Provision for diminution in value (S\$’000) |
0 |
0 |
Important Information for Shareholders
-
Significant Investment Exposure: After the latest acquisition, the aggregate cost of the Group’s quoted investments now stands at 207.2% of the Group’s net tangible assets. This is a significant exposure and substantially exceeds the Group’s NTA.
-
No Provision for Diminution: There is currently no provision for diminution in the value of these quoted investments, indicating the Group’s confidence in the market value of its holdings.
-
Potential Share Price Impact: Given the scale of the Group’s investment in quoted securities relative to its NTA, any significant market movement in the value of these investments could materially impact the Group’s financial position and, consequently, its share price.
-
Transparency and Regulatory Compliance: The Company’s disclosure complies with SGX listing rules, providing transparency into its investment activities.
Shareholders should closely monitor further announcements from mDR Limited regarding its investment activities, as changes in the value of quoted securities could have a pronounced effect on the Group’s financial results and share valuation.
Corporate Governance Note
The announcement was authorized by Madan Mohan, Company Secretary, on 5 January 2026.
Disclaimer: This article is prepared for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions.
View MDR Limited Historical chart here
